Open AccessFDA recalled Ranitidine: What about the consumers who ate Ranitidine with carcinogenic impurity by paying to Pharma companies?
Author(s) -
Aslam Pathan,
NeuroPharmac Journal
Publication year - 2019
Publication title -
neuropharmac journal
Language(s) - English
Resource type - Journals
ISSN - 2456-3927
DOI - 10.37881/1.431
Subject(s) - ranitidine , business , pharmacology , carcinogen , impurity , medicine , chemistry , biochemistry , organic chemistry